# Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)

> **NCT06894823** · — · RECRUITING · sponsor: **National Cancer Institute, Naples** · enrollment: 16000 (estimated)

## Conditions studied

- Neoplasm

## Interventions

- **OTHER:** Creation of a laboratory network
- **OTHER:** Mapping of genomic alterations
- **OTHER:** Creation of a bioinformatics network among the participating institutions.
- **OTHER:** Development of a platform for the collection of clinicopathological and genetic-molecular data.
- **OTHER:** Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

## Key facts

- **NCT ID:** NCT06894823
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 16000 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894823, "Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06894823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*